Augustijns Patrick, Vertzoni Maria, Reppas Christos, Langguth Peter, Lennernäs Hans, Abrahamsson Bertil, Hasler William L, Baker Jason R, Vanuytsel Tim, Tack Jan, Corsetti Maura, Bermejo Marival, Paixão Paulo, Amidon Gordon L, Hens Bart
Drug delivery & Disposition, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven Herestraat 49, box 921, 3000 Leuven, Belgium.
Department of Pharmacy, School of Health Sciences, National and Kapodistrian University of Athens, Greece.
Eur J Pharm Sci. 2020 Dec 1;155:105517. doi: 10.1016/j.ejps.2020.105517. Epub 2020 Aug 18.
Fluid sampling from the gastrointestinal (GI) tract has been applied as a valuable tool to gain more insight into the fluids present in the human GI tract and to explore the dynamic interplay of drug release, dissolution, precipitation and absorption after drug product administration to healthy subjects. In the last twenty years, collaborative initiatives have led to a plethora of clinical aspiration studies that aimed to unravel the luminal drug behavior of an orally administered drug product. The obtained drug concentration-time profiles from different segments in the GI tract were a valuable source of information to optimize and/or validate predictive in vitro and in silico tools, frequently applied in the non-clinical stage of drug product development. Sampling techniques are presently not only being considered as a stand-alone technique but are also used in combination with other in vivo techniques (e.g., gastric motility recording, magnetic resonance imaging (MRI)). By doing so, various physiological variables can be mapped simultaneously and evaluated for their impact on luminal drug and formulation behavior. This comprehensive review aims to describe the history, challenges and opportunities of the aspiration technique with a specific focus on how this technique can unravel the luminal behavior of drug products inside the human GI tract by providing a summary of studies performed over the last 20 years. A section 'Best practices' on how to perform the studies and how to treat the aspirated samples is described. In the conclusion, we focus on future perspectives concerning this technique.
从胃肠道(GI)采集流体样本已成为一种有价值的工具,有助于更深入了解人体胃肠道中的流体,并探索药物产品给药于健康受试者后药物释放、溶解、沉淀和吸收的动态相互作用。在过去二十年中,合作项目催生了大量临床抽吸研究,旨在揭示口服药物产品在管腔内的行为。从胃肠道不同部位获得的药物浓度-时间曲线是优化和/或验证预测性体外和计算机模拟工具的宝贵信息来源,这些工具常用于药物产品开发的非临床阶段。目前,采样技术不仅被视为一种独立技术,还与其他体内技术(如胃动力记录、磁共振成像(MRI))结合使用。通过这样做,可以同时绘制各种生理变量,并评估它们对管腔内药物和制剂行为的影响。这篇综述旨在描述抽吸技术的历史、挑战和机遇,特别关注该技术如何通过总结过去20年进行的研究来揭示人体胃肠道内药物产品的管腔行为。文中还描述了关于如何进行研究以及如何处理抽吸样本的“最佳实践”部分。在结论部分,我们关注该技术的未来前景。